Clinical trial
The Efficacy and Safety of Berberine in the Treatment of Type 2 Diabetes With Dyslipidemia
NCT00462046 is registered in ClinicalTrials.gov with Shanghai Jiao Tong University School of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Efficacy and Safety of Berberine in the Treatment of Type 2 Diabetes With Dyslipidemia
- Lead sponsor
- Shanghai Jiao Tong University School of Medicine
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- April 30, 2005
- Completion date
- September 30, 2006
- Enrollment
- 120
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.